New models used writing samples to predict the onset of the disease with 70 percent accuracy
Neurological symptoms might arise from multiple causes. But does the virus even get into neurons?
Targeting recall processes could let people who are in the disease’s early stages access what they currently can’t remember
His start-up Neuralink is not the first to develop a wireless brain implant. But the considerable resources behind the effort could help commercialize the technology faster
Research suggests that cultural beliefs about the phenomenon may make it more terrifying to experience
Sleep hygiene is so bad at treating insomnia that it's used as the placebo in clinical sleep trials. Before you buy darker blackout curtains, try these expert tips
Toxic airborne particles can travel from lungs and nose to the brain, and exposure is linked to memory loss
Rigorous new studies should be able to settle the matter
Being female is a risk factor for Alzheimer’s. Why?
Amyloid, the leading target for dementia therapy, faces skepticism after drug failures
Here are some “highlights” from the past 13.5 years of this podcast.
Fresh approaches and hopeful clues in the search for novel therapies
Some nominally high-risk individuals may have a lower chance of developing dementia than once thought
A new era for Alzheimer’s and journalism in the time of coronavirus
It is time for a fresh approach to the illness
Alzheimer’s took my wife’s memory and her life and tortured our family. There was nothing we—or medicine—could do to stop it
Most autistic individuals want to and can make friends, though their relationships often have a distinctive quality
The protein, once seen as a secondary player, has taken a leading role in combating neurodegenerative illnesses
Such children’s neural circuits do not transition properly from an active state to a resting one
Particular antioxidants in fruits and vegetables may lower chances of getting the disease